‘Watch and wait’ good for most, but not all, rectal cancers

Описание к видео ‘Watch and wait’ good for most, but not all, rectal cancers

Rectal tumors regrow in about 20%-30% of watch-and-wait patients, following chemotherapy and radiation. Right now, there's no way to tell apart people who will be cured by neoadjuvant therapy from those who will regrow their tumors, who probably should have undergone up-front surgery. Dr. Philip Paty, a colorectal surgeon at Memorial Sloan Kettering Cancer Center, Manhattan, offered his advice on how to handle the situation in an interview at the American College of Surgeons Clinical Congress. For more details, visit www.mdedge.com.

Комментарии

Информация по комментариям в разработке

Похожие видео